GGrantIndex
Sort

78,016 grants matching breast cancer

Clinical Protocol and Data Management (Core 018)

$689,776
Elizabeth C Dees · Univ Of North Carolina Chapel Hill · P30 · FY2020 · CA

Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic

$689,677
Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2021 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays

$689,664
Joshua Labaer · Arizona State University-Tempe Campus · U01 · FY2013 · CA

Leveraging machine learning to improve risk prediction for chemotherapy inducedneuropathy

$689,634
Alyce Sophia Adams · Stanford University · R01 · FY2021 · CA

Temporal Analysis of Mammary Carcinogenesis

$689,619
University Of Pennsylvania · R33 · FY2004 · CA

Fox Chase Clinical Epidemiology and Validation Center

$689,613
Paul F. Engstrom · Research Inst Of Fox Chase Can Ctr · U01 · FY2014 · CA

Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT

$689,605
Michael R Bishop · Clinical Sciences · Z01 · FY2007 · CA

Integrating Tobacco Treatment into Cancer Care

$689,597
Elyse R Park · Massachusetts General Hospital · R01 · FY2015 · CA

SAN FRANCISCO MAMMOGRAPHY REGISTRY--A RESEARCH RESOURCE

$689,587
University Of California San Francisco · U01 · FY2000 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Harvard Medical School · R01 · FY2013 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$689,580
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA

Partnership-3: multimode quantitative ultrasound prototype breast scanner

$689,559
James W Wiskin · Qt Imaging, Inc. · R01 · FY2014 · CA

Recombination and Regulation

$689,423
Jeffrey Strathern · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1

$689,321
Jane Amanda Skok · New York University School Of Medicine · R01 · FY2023 · CA

Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV

$689,270
Sumita Bhaduri-McIntosh · University Of Florida · U01 · FY2022 · CA

RCT of exercise on aromatase inhibitor side effects in breast cancer survivors

$689,238
Melinda L Irwin · Yale University · R01 · FY2009 · CA

Hawaii Pacific Islands Mammography Registry

$688,923
John Alan Shepherd · University Of Hawaii At Manoa · R01 · FY2023 · CA

Physical Activity, Sedentary Behavior, and Cancer Incidence in Women

$688,906
Kelly Evenson · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

Clinical trials employing cancer vaccine combination therapies

$688,838
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Phase II Clinical Trial of Polyphenon E in Prostate Cancer

$688,824
Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA

PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2

$688,795
University Of Pennsylvania · R01 · FY2001 · CA

Ultrasound imaging and local drug delivery in tumors

$688,753
Katherine W Ferrara · University Of California At Davis · R01 · FY2012 · CA

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$688,740
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Stromal contributions to breast carcinogenesis

$688,712
Lusine Yaghjyan · University Of Florida · R01 · FY2025 · CA